File HB4219 ("Expands epinephrine options in Illinois schools") is before the Illinois Legislature and has not been decided. Latest step (March 27, 2026): Rule 19(a) / Re-referred to Rules Committee.
Illinois file HB4219, before the Illinois Legislature. Still to be decided as of 2026-03-27.
Students get access to more epinephrine delivery formats Starting July 30, 2026, Illinois schools can administer epinephrine via newer FDA-approved delivery systems (such as auto-injectors, nasal sprays, or other non-injector forms) in addition to traditional injectors, giving students with severe allergies more treatment options.
School staff training expands to cover new epinephrine formats Schools must now ensure staff completing anaphylaxis training receive certification and are trained on proper administration of whichever epinephrine delivery system the school stocks, potentially requiring updates to existing training curricula and certification processes.
Amends the School Code. Changes the term "epinephrine injector" to "epinephrine delivery system" in a provision regarding the self-administration, self-carry, and administration of epinephrine delivery systems. Defines "epinephrine delivery system" as any form of epinephrine that is approved by the United States Food and Drug Administration and that is used to administer epinephrine into the human body to prevent or treat a life-threatening allergic reaction. Requires the entity or individual conducting the training curriculum to recognize and respond to anaphylaxis to issue a certificate to each person who successfully completes the anaphylaxis training program. Allows the anaphylaxis training to include the proper techniques for administering non-injector epinephrine options. Effective July 30, 2026.
Read the official record for HB4219
See everything up for a vote · This week in Illinois · See what we have filed with the clerk